Prevalence and management of patients using medication targeting obstructive lung disease:A cross-sectional study in primary healthcare in Greenland

OBJECTIVE: The aim of this study was to estimate the prevalent use of drugs targeting obstructive lung diseases among adults aged 50 or above in Greenland and to assess the use of spirometry testing among these medication users. STUDY DESIGN: Observational cross-sectional study based on reviews of e...

Full description

Bibliographic Details
Published in:International Journal of Circumpolar Health
Main Authors: Olsen, Sequssuna, Jarbøl, Dorte Ejg, Koefoed, Mette, Abildskov, Kim, Pedersen, Michael Lynge
Format: Article in Journal/Newspaper
Language:English
Published: 2013
Subjects:
Aged
Arctic Regions
Cross-Sectional Studies
Drug Utilization
Female
Greenland
Humans
Lung Diseases
Obstructive
Male
Middle Aged
Prevalence
Primary Health Care
Spirometry
Arctic
Circumpolar Health
International Journal of Circumpolar Health
Online Access:https://portal.findresearcher.sdu.dk/da/publications/4885ded2-bb2c-4906-8c07-13f43f4a88ca
https://doi.org/10.3402/ijch.v72i0.20108
Description
Summary:OBJECTIVE: The aim of this study was to estimate the prevalent use of drugs targeting obstructive lung diseases among adults aged 50 or above in Greenland and to assess the use of spirometry testing among these medication users. STUDY DESIGN: Observational cross-sectional study based on reviews of electronic medical records. METHODS: The study was performed in the 6 largest primary healthcare clinics in Greenland, representing approximately 67.0% of the population in Greenland. Adults aged 50 years or above, who had at least one electronically prescribed drug targeting obstructive lung diseases within a 15-month time interval, were identified. We assessed whether a spirometry test was registered in their medical records within previous 2- and 4-year periods. RESULTS: A total of 565 persons were identified. This corresponds to a prevalent medication use of 6.1% (565/9,023) among adults aged 50 years or above. Among these medication users, 14.1% (80/565) had a spirometry test performed within 2 years. Within the 4-year period this increased to 17.9% (101/565). CONCLUSION: The use of medication targeting obstructive lung diseases in Greenland among adults aged 50 years or above is common. However, spirometry testing among medication users is low and interventions aiming to increase focus on spirometry testing should be integrated in the primary healthcare system.

Similar Items